{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:17Z","timestamp":1786119617148,"version":"build-2736575974"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,1]]},"DOI":"10.1097\/qai.0b013e318209754c","type":"journal-article","created":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T03:03:23Z","timestamp":1297393403000},"page":"S39-S45","source":"Crossref","is-referenced-by-count":54,"title":["Improved Quality of Life for Opioid-Dependent Patients Receiving Buprenorphine Treatment in HIV Clinics"],"prefix":"10.1097","volume":"56","author":[{"given":"P Todd","family":"Korthuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jo","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Botsko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N","family":"Gourevitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Boverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick L","family":"Altice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20210131","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archpsyc.58.8.721","article-title":"Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.","volume":"58","author":"Bing","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"R3-7-20210131","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jsat.2007.11.005","article-title":"Substance abuse treatment in human immunodeficiency virus: the role of patient-provider discussions.","volume":"35","author":"Korthuis","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"R5-7-20210131","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1008919227665","article-title":"Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study.","volume":"9","author":"Bing","year":"2000","journal-title":"Qual Life Res"},{"key":"R6-7-20210131","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0002-9343(00)00387-9","article-title":"Health-related quality of life in patients with Human Immunodeficiency Virus infection in the United States: results from the HIV Cost and Services Utilization Study.","volume":"108","author":"Hays","year":"2000","journal-title":"Am J Med"},{"key":"R7-7-20210131","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1310\/48ET-TT7G-35RA-D4C3","article-title":"Health-related quality of life in individuals infected with HIV in the Era of HAART.","volume":"2","author":"Miners","year":"2001","journal-title":"HIV Clin Trials"},{"key":"R8-7-20210131","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1111\/j.1525-1497.2006.00644.x","article-title":"Health-related quality of life in veterans and nonveterans with HIV\/AIDS.","volume":"21","author":"Mrus","year":"2006","journal-title":"J Gen Intern Med"},{"key":"R9-7-20210131","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s11136-005-6010-x","article-title":"Changes in symptoms and health-related quality of life in a nationally representative sample of adults in treatment for HIV.","volume":"15","author":"Lorenz","year":"2006","journal-title":"Qua Life Res"},{"key":"R11-7-20210131","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1089\/aid.2007.0067","article-title":"Health-related quality of life outcomes in HIV-infected patients starting different combination regimens in a randomized multinational trial: the INITIO-QoL substudy.","volume":"23","author":"Bucciardini","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R12-7-20210131","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1097\/00002030-200110190-00011","article-title":"Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection.","volume":"15","author":"Nieuwkerk","year":"2001","journal-title":"AIDS"},{"key":"R13-7-20210131","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/apc.2005.19.563","article-title":"Beyond efficacy: the impact of combination antiretroviral therapy on quality of life.","volume":"19","author":"Sax","year":"2005","journal-title":"AIDS Patient Care STDS"},{"key":"R14-7-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1525-1497.2005.30402.x","article-title":"The association of health-related quality of life with survival among persons with HIV infection in the United States.","volume":"20","author":"Cunningham","year":"2005","journal-title":"J Gen Intern Med"},{"key":"R15-7-20210131","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00002030-200202150-00015","article-title":"Assessing the utility of five domains in SF-12 Health Status Questionnaire in an AIDS clinical trial.","volume":"16","author":"Han","year":"2002","journal-title":"AIDS"},{"key":"R16-7-20210131","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0895-4356(03)00062-3","article-title":"Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease.","volume":"56","author":"Jacobson","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"R17-7-20210131","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1089\/apc.2008.0005","article-title":"Health-related quality of life in HIV-infected patients: the role of substance use.","volume":"22","author":"Korthuis","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"R18-7-20210131","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.drugalcdep.2006.06.012","article-title":"Health related quality of life among both current and former injection drug users who are HIV-infected.","volume":"86","author":"Preau","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"R19-7-20210131","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s11136-004-4715-x","article-title":"Health-related quality of life of patients with HIV: impact of sociodemographic, clinical and psychosocial factors.","volume":"14","author":"Ruiz Perez","year":"2005","journal-title":"Qual Life Res"},{"key":"R20-7-20210131","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/10826080701204813","article-title":"Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment.","volume":"43","author":"Astals","year":"2008","journal-title":"Subst Use Misuse"},{"key":"R21-7-20210131","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1874473710902010005","article-title":"Measuring the impact of psychoactive substance on health-related quality of life: an update.","volume":"2","author":"Gonzalez-Saiz","year":"2009","journal-title":"Curr Drug Abuse Rev"},{"key":"R22-7-20210131","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1081\/JA-120039392","article-title":"Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender.","volume":"39","author":"Puigdollers","year":"2004","journal-title":"Subst Use Misuse"},{"key":"R23-7-20210131","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archpsyc.58.8.729","article-title":"Use of mental health and substance abuse treatment services among adults with HIV in the United States.","volume":"58","author":"Burnam","year":"2001","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 1","key":"R24-7-20210131","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/QAI.0b013e318209740f","article-title":"A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care.","volume":"56","author":"Cheever","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-7-20210131","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/ADM.0b013e3181cc9610","article-title":"Patients reasons for choosing office-based Buprenorphine: preference for patient-centered care.","volume":"4","author":"Korthuis","year":"2010","journal-title":"J Addict Med"},{"key":"R26-7-20210131","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research.","volume":"28","author":"Amato","year":"2005","journal-title":"J Subst Abuse Treat"},{"key":"R27-7-20210131","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1100\/tsw.2005.52","article-title":"Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment.","volume":"5","author":"Giacomuzzi","year":"2005","journal-title":"ScientificWorldJournal"},{"key":"R28-7-20210131","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1360-0443.2003.00352.x","article-title":"Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health-related quality of life assessment.","volume":"98","author":"Giacomuzzi","year":"2003","journal-title":"Addiction"},{"key":"R29-7-20210131","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/00952990701523698","article-title":"Quality of life among heroin users on buprenorphine versus methadone maintenance.","volume":"33","author":"Ponizovsky","year":"2007","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R30-7-20210131","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3109\/10826080902873010","article-title":"Improved quality of life, clinical, and psychosocial outcomes among heroin-dependent patients on ambulatory buprenorphine maintenance.","volume":"45","author":"Ponizovsky","year":"2010","journal-title":"Subst Use Misuse"},{"key":"R31-7-20210131","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1080\/09540120802657555","article-title":"Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy.","volume":"21","author":"Springer","year":"2009","journal-title":"AIDS Care"},{"key":"R33-7-20210131","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.02.003","article-title":"Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: the role of methadone maintenance therapy.","volume":"84","author":"Palepu","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"R34-7-20210131","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(00)80010-1","article-title":"Drug abuse, methadone treatment, and health services use among injection drug users with AIDS.","volume":"60","author":"Sambamoorthi","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 1","key":"R35-7-20210131","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/QAI.0b013e3182097426","article-title":"The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine\/naloxone and HIV treatment.","volume":"56","author":"Weiss","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R36-7-20210131","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity.","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"R38-7-20210131","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0149-2918(00)80088-0","article-title":"The discriminative ability of the 12-item short form health survey (SF-12) in a sample of persons infected with HIV.","volume":"22","author":"Delate","year":"2000","journal-title":"Clin Ther"},{"key":"R39-7-20210131","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s11136-004-3507-7","article-title":"Nature and correlates of SF-12 physical and mental quality of life components among low-income HIV adults using an HIV service center.","volume":"14","author":"Viswanathan","year":"2005","journal-title":"Qual Life Res"},{"key":"R40-7-20210131","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/00005650-200011000-00008","article-title":"Reliability and validity of the SF-12 health survey among people with severe mental illness.","volume":"38","author":"Salyers","year":"2000","journal-title":"Med Care"},{"key":"R41-7-20210131","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/1475-6773.00046","article-title":"Use of the SF-12 instrument for measuring the health of homeless persons.","volume":"37","author":"Larson","year":"2002","journal-title":"Health Serv Res"},{"key":"R42-7-20210131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/pubmed\/23.3.187","article-title":"An assessment of the construct validity of the SF-12 summary scores across ethnic groups.","volume":"23","author":"Jenkinson","year":"2001","journal-title":"J Public Health Med"},{"key":"R43-7-20210131","first-page":"A44","article-title":"Validity of the SF-12 for use in a low-income African American community-based research initiative (REACH 2010).","volume":"5","author":"Larson","year":"2008","journal-title":"Prev Chronic Dis"},{"key":"R44-7-20210131","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2006.09.002","article-title":"Initial evidence for the reliability and validity of a Lite version of the Addiction Severity Index.","volume":"87","author":"Cacciola","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"R45-7-20210131","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.","volume":"168","author":"McLellan","year":"1980","journal-title":"J Nerv Ment Dis"},{"key":"R46-7-20210131","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index.","volume":"9","author":"McLellan","year":"1992","journal-title":"J Subst Abuse Treat"},{"key":"R47-7-20210131","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial.","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"key":"R48-7-20210131","first-page":"830","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA. 2008;300:2003-2011.","volume":"301","author":"Woody","year":"2009","journal-title":"Erratum appears in JAMA"},{"key":"R49-7-20210131","doi-asserted-by":"crossref","first-page":"704","DOI":"10.7326\/0003-4819-152-11-201006010-00003","article-title":"Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: a randomized trial.","volume":"152","author":"Lucas","year":"2010","journal-title":"Ann Intern Med"},{"key":"R52-7-20210131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000083035","article-title":"Gender differences in health-related quality of life on admission to a maintenance treatment program.","volume":"11","author":"Giacomuzzi","year":"2005","journal-title":"Eur Addict Res"},{"key":"R53-7-20210131","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00126334-200208150-00004","article-title":"Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life.","volume":"30","author":"Gill","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R54-7-20210131","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10461-007-9246-3","article-title":"The effects of housing status on health-related outcomes in people living with HIV: a systematic review of the literature.","volume":"11","author":"Leaver","year":"2007","journal-title":"AIDS Behav"},{"issue":"Suppl 1","key":"R55-7-20210131","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/QAI.0b013e31820a8226","article-title":"Integration of buprenorphine\/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative.","volume":"56","author":"Weiss","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R57-7-20210131","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/hec.866","article-title":"A comparison of the EQ-5D and SF-6D across seven patient groups.","volume":"13","author":"Brazier","year":"2004","journal-title":"Health Econ"},{"key":"R58-7-20210131","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11136-008-9429-z","article-title":"Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D.","volume":"18","author":"Szende","year":"2009","journal-title":"Qual Life Res"},{"key":"R59-7-20210131","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/00007632-199909010-00010","article-title":"Responsiveness of common outcome measures for patients with low back pain.","volume":"24","author":"Taylor","year":"1999","journal-title":"Spine"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e318209754c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:45:05Z","timestamp":1786041905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201103011-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":51,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318209754c","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}